MLYS (Mineralys Therapeutics, Inc.) Stock Financials & Earnings

MLYSMineralys Therapeutics, Inc.

Mkt Cap$2B

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$171M

EPS (TTM)-$2.95

Free Cash Flow (TTM)-$171M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth—

Employees—

Earnings Reports

Next: Q4 2025 · Mar 11

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$0	$0	-$10M
Q1 23	$0	$0	-$15M
Q2 23	$0	$0	-$16M
Q3 23	$0	$0	-$26M
Q4 23	$0	$0	-$28M
Q1 24	$0	-$8K	-$35M
Q2 24	$0	$0	-$45M
Q3 24	$0	$0	-$60M
Q4 24	$0	$0	-$52M
Q1 25	$0	$0	-$44M
Q2 25	$0	$0	-$47M
Q3 25	$0	-$15K	-$41M

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$88M	$22M	$110M
Q1 23	$138M	$132M	$271M
Q2 23	$101M	$160M	$261M
Q3 23	$86M	$167M	$254M
Q4 23	$49M	$187M	$237M
Q1 24	$90M	$248M	$339M
Q2 24	$68M	$243M	$311M
Q3 24	$97M	$166M	$264M
Q4 24	$114M	$84M	$198M
Q1 25	$165M	$178M	$343M
Q2 25	$102M	$223M	$325M
Q3 25	$218M	$0	$218M

Shares Outstanding

Revenue Per Employee

Revenue / Employee